1-Boc-1,8-diaza-spiro[4.5]decane

Catalog No.: 
ACBCZV150
CAS No.: 
885279-92-5
Molecular Formula: 
C13H24N2O2
Molecular Weight: 
240.35
1-Boc-1,8-diaza-spiro[4.5]decane structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$65.00In stockIn stock
1g95%$185.00In stockIn stock
5g95%$742.00In stockIn stock
25g95%$3599.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-Boc-1,8-diaza-spiro[4.5]decane
IUPAC Nametert-butyl 1,8-diazaspiro[4.5]decane-1-carboxylate
MDL No.MFCD06739037
Molecular FormulaC13H24N2O2
Molecular Weight240.35
SMILESO=C(N1CCCC12CCNCC2)OC(C)(C)C
InChI KeyAGYJKDRKBSJWLJ-UHFFFAOYSA-N
Synonym885279-92-5 | 1-Boc-1,8-diaza-spiro[4.5]decane | tert-butyl 1,8-diazaspiro[4.5]decane-1-carboxylate | 1,8-Diaza-spiro[4.5]decane-1-carboxylic acid tert-butyl ester | 1,8-Diazaspiro[4.5]decane-1-carboxylic acid tert-butyl ester | MFCD06739037 | 1-Boc-1,8-diazaspiro[4.
CAS No.885279-92-5
PubChem CID34178602

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACBCZV150 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACWHDK729 route compound structure diagram
    ACWHDK729928034-31-5In Stock
  2. Then
  3. ACBCZV150 route product structure diagram
    ACBCZV150885279-92-5In Stock
Inquiry

2. ACBCZV150 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBCZV150 route product structure diagram
    ACBCZV150885279-92-5In Stock
Inquiry

3. ACBCZV150 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBCZV150 route product structure diagram
    ACBCZV150885279-92-5In Stock
Inquiry

Comments (0)